Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

Clotting Disorders Clinical Trial

Official title:
Mobius PT-INR Accuracy Clinical Study

Status Completed

Clinical Trial Summary

The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01375725
Study type	Observational
Source	Universal Biosensors Pty Ltd
Contact
Status	Completed
Phase	N/A
Start date	September 2010
Completion date	September 2010

View Details

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT03520712` - Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5	Phase 1/Phase 2